Trial Profile
Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 14 Aug 2010 New trial record